Physician profile

Dilys A Whyte

Pediatric Nephrology · West Islip, NY

NPI 1760424881

$2,508.46

in general payments reported to CMS, 2019-2025

40 companies · $482 in 2025

The $482 reported for 2025 was more than what 75% of Pediatric Nephrology providers received nationally (typical 2025 total: $131).

See the full distribution for Pediatric Nephrology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,551.89

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Mallinckrodt Enterprises LLC $247.62 2019
Genzyme Corporation $246.56 2021-2024
Corium, LLC $213.77 2023-2025 Azstarys
Supernus Pharmaceuticals, INC. $175.13 2022-2025 Qelbree, Qelbree
Ironshore Pharmaceuticals INC. $164.52 2019-2024 Jornay Pm
Neurelis, INC. $117.00 2020-2024 Valtoco
Ucb, INC. $114.89 2022-2025 Fintepla, Cimzia
Alexion Pharmaceuticals, INC. $98.05 2024-2025 Koselugo, Strensiq
Sunovion Pharmaceuticals INC. $66.77 2019
Baxter Healthcare $66.48 2023-2025 Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care
Global Blood Therapeutics, INC. $60.04 2020-2022
Tandem Diabetes Care, INC. $59.54 2022-2024 T:Slim X2 Insulin Pump With Control-Iq
Medtronic, INC. $59.26 2024 Minimed 780g
Azurity Pharmaceuticals, INC. $59.25 2025 Triptodur
Takeda Pharmaceuticals U.S.A., INC. $56.58 2024-2025 Eohilia
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Acadia Pharmaceuticals INC $52.75 2023-2024 Daybue
Neos Therapeutics, LP $51.76 2023-2025 Adzenys Xr-Odt, Cotempla Xr-Odt
Ascendis Pharma Endocrinology INC $47.72 2025 Skytrofa
Glaxosmithkline, LLC. $43.28 2021-2023 Nucala
Vertical Pharmaceuticals, LLC $41.26 2019
Abbvie INC. $38.41 2025
Greenwich Biosciences, INC. $34.53 2019-2021
Collegium Pharmaceutical, INC. $32.46 2025 Jornay Pm
Biomarin Pharmaceutical INC. $31.46 2022-2023 Voxzogo 1.2mg
Novo Nordisk INC $31.28 2020-2024 Rivfloza
Sobi, INC $31.25 2023
Grifols USA, LLC $29.59 2025 Xembify
Ultragenyx Pharmaceutical INC. $27.73 2019-2021
Mirum Pharmaceuticals, INC. $23.34 2023 Livmarli
Catalyst Pharmaceuticals, INC. $22.44 2024
Zogenix INC. $22.01 2021
Xeris Pharmaceuticals, INC. $21.32 2024 Gvoke Hypopen
Leadiant Biosciences, INC. $18.35 2019
Boehringer Ingelheim Pharmaceuticals, INC. $16.84 2020
Ferring Pharmaceuticals INC. $15.73 2020
Cranial Technologies, INC $14.90 2020
Adlon Therapeutics L.P. $14.22 2020
Tris Pharma INC $13.98 2020
Janssen Biotech, INC. $13.65 2025 Tremfya
Cognoa, INC. $12.74 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Dilys A Whyte

$2,508.46

in general payments reported 2019-2025

Years
2019-2025
Top company
Mallinckrodt Enterprises LLC
Context
The $482 reported for 2025 was more than what 75% of Pediatric Nephrology providers received nationally (typical 2025 total: $131).

https://glasscript.com/doctor/1153611/dilys-a-whyte

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.